These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pseudomyxoma peritonei induced by low-grade appendiceal mucinous neoplasm accompanied by rectal cancer: a case report and literature review. Ning S, Yang Y, Wang C, Luo F. BMC Surg; 2019 Apr 25; 19(1):42. PubMed ID: 31023277 [Abstract] [Full Text] [Related]
8. Pseudomyxoma peritonei associated with mucinous adenocarcinoma of the pancreas: CT findings and CT-guided biopsy. Gustafson KD, Karnaze GC, Hattery RR, Scheithauer BW. J Comput Assist Tomogr; 1984 Apr 25; 8(2):335-8. PubMed ID: 6323557 [Abstract] [Full Text] [Related]
9. Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Chua TC, Al-Zahrani A, Saxena A, Glenn D, Liauw W, Zhao J, Morris DL. Ann Surg Oncol; 2011 Jun 25; 18(6):1582-9. PubMed ID: 21207170 [Abstract] [Full Text] [Related]
10. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Sugarbaker PH. Eur J Surg Oncol; 2001 Apr 25; 27(3):239-43. PubMed ID: 11373099 [Abstract] [Full Text] [Related]
11. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Sugarbaker PH, Landy D, Jaffe G, Pascal R. Cancer; 1990 Apr 01; 65(7):1495-501. PubMed ID: 2107021 [Abstract] [Full Text] [Related]
14. Laparoscopic management of pseudomyxoma peritonei secondary to adenocarcinoma of the appendix. Raj J, Urban LM, ReMine SG, Raj PK. J Laparoendosc Adv Surg Tech A; 1999 Jun 01; 9(3):299-303. PubMed ID: 10414551 [Abstract] [Full Text] [Related]
15. Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin. Järvinen P, Ristimäki A, Kantonen J, Lepistö A. Scand J Surg; 2013 Jun 01; 102(3):145-51. PubMed ID: 23963027 [Abstract] [Full Text] [Related]
16. Management of mucinous urachal neoplasm presenting as pseudomyxoma peritonei. Sugarbaker PH, Verghese M, Yan TD, Brun E. Tumori; 2008 Jun 01; 94(5):732-6. PubMed ID: 19112949 [Abstract] [Full Text] [Related]
17. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M. Ann Surg Oncol; 2008 Feb 01; 15(2):526-34. PubMed ID: 18043976 [Abstract] [Full Text] [Related]
18. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Zoetmulder FA, Sugarbaker PH. Eur J Cancer; 1996 Sep 01; 32A(10):1727-33. PubMed ID: 8983281 [Abstract] [Full Text] [Related]
19. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Eur J Surg Oncol; 2015 Mar 01; 41(3):396-9. PubMed ID: 25216980 [Abstract] [Full Text] [Related]
20. [Intraperitoneal administration of a combined CDDP, 5-FU and MMC therapy for pseudomyxoma peritonei]. Sasaki A, Terashima M, Okamoto K, Ikeda K, Takagane A, Takiyama I, Shimada Y, Yamamoto M, Nakajima J, Sasaki N, Saito K. Gan To Kagaku Ryoho; 1999 Oct 01; 26(12):1828-31. PubMed ID: 10560405 [Abstract] [Full Text] [Related] Page: [Next] [New Search]